Evidence map›Paper›PMID 34353291›Full record

ArticleBMC neurology2021

Longitudinal Changes of Tongue Thickness and Tongue Pressure in Neuromuscular Disorders.

George Umemoto, Shinsuke Fujioka, Hajime Arahata, Nobutaka Sakae, Naokazu Sasagasako, Mine Toda, Hirokazu Furuya, Yoshio Tsuboi

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

George UmemotoSwallowing Disorders Center, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan. george@fukuoka-u.ac.jp.ORCID http://orcid.org/0000-0002-8458-1329
Shinsuke FujiokaDepartment of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Hajime ArahataDepartment of Neurology, Neuro-Muscular Center, NHO Omuta National Hospital, Fukuoka, Japan.
Nobutaka SakaeDepartment of Neurology, Neuro-Muscular Center, NHO Omuta National Hospital, Fukuoka, Japan.
Naokazu SasagasakoDepartment of Neurology, Neuro-Muscular Center, NHO Omuta National Hospital, Fukuoka, Japan.
Mine TodaDepartment of Clinical Nutrition & Food services, NHO Omuta National Hospital, Fukuoka, Japan.
Hirokazu FuruyaDepartment of Neurology, Faculty of Medicine, Kochi University, Kochi, Japan.
Yoshio TsuboiDepartment of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Omuta hospital · JPFukuoka University · JPFukuoka University Hospital · JPUniversity of Kochi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSwallowing dysfunction is related to major cause of adverse events and an indicator of shorter survival among patients with neuromuscular disorders (NMD). It is critical to assess the swallowing function during disease progression, however, there are limited tools that can easily evaluate swallowing function without using videofluoroscopic or videoendoscopic examination. Here, we evaluated the longitudinal changes in tongue thickness (TT) and maximum tongue pressure (MTP) among patients with amyotrophic lateral sclerosis (ALS), myotonic dystrophy type 1 (DM1), and Duchenne muscular dystrophy (DMD).

methodsBetween 2010 and 2020, TT and MTP were measured from 21 ALS, 30 DM1, and 14 DMD patients (mean ages of 66.9, 44.5, and 21.4 years, respectively) at intervals of more than half a year. TT was measured, by ultrasonography, as the distance from the mylohyoid muscle raphe to the tongue dorsum, and MTP was determined by measuring the maximum compression on a small balloon when pressing the tongue against the palate. Then we examined the relationship between these evaluations and patient background and swallowing function.

resultsMean follow-up periods were 24.0 months in the ALS group, 47.2 months in the DM1group, and 61.1 months in the DMD group. The DMD group demonstrated larger first TT than the other groups, while the DM1 group had lower first MTP than the ALS group. The ALS group showed a greater average monthly reduction in mean TT than the DM1 group and greater monthly reductions in mean body weight (BW) and MTP than the other groups. Significant differences between the first and last BW, TT, and MTP measures were found only in the ALS group.

conclusionsThis study suggests that ALS is associated with more rapid degeneration of tongue function over several years compared to DMD and DM1.

Indexed as

Deglutition DisordersNeuromuscular DiseasesTongueAmyotrophic Lateral SclerosisDeglutitionHumansPressureAmyotrophic lateral sclerosisDuchenne muscular dystrophyMyotonic dystrophy type 1Tongue pressureTongue thickness

Identifiers

PMID34353291
PMCPMC8340465
OpenAlexW3111603219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.